Fundraising Fox
/Companies
Sign in

Anthrogen

YC S24

San Francisco, US · Founded 2024 · 15 employees · Hiring · 12 known investors

Find your way into Anthrogen

Sign up to see every warm intro you have to Anthrogen

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Anthrogen team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Anthrogen develops Odyssey, a family of protein language models with 102 billion parameters designed for multi-objective protein design. The models provide an API for researchers and organizations in biotechnology and drug discovery.

Also known as Arctic Capture, Inc. · Arctic Capture

AI & Machine LearningBiotechDeep TechHealthtechDeep LearningAIUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (S24)

Anthrogen was founded in 2024 by Ankit Singhal, Connor Lee, and Vignesh Karthik.

ASAnkit Singhal
Ankit SinghalCo-founder and CEOAnkit Singhal is CEO of Anthrogen and previously held a research fellowship at Columbia. He has laboratory experience in catalysis, structural biology, and biophysics, with published research from his early academic career.30 Under 30 2025
CLConnor Lee
Connor LeeCo-Founder and CTOHe previously conducted research at Columbia University's ROAM Lab and held a leadership position in Columbia's robotics program, with over a decade of experience in robotics competitions.30 Under 30 2025
VKVignesh Karthik
Vignesh KarthikCo-Founder and COO2024–202530 Under 30 2025
SV
Shyam VenkatasubramanianHead of technical staff
SM
Sean Moushegianmember of technical staff
ML
Michael Linmots

Investors · 12

BoxGrouplisted by BoxGroupNew York · $250K – $1M

How we know: BoxGroup's portfolio page · funding news · the VCSheet dataset · open dataset · 5k.vc investor directory · Y Combinator's founder network · Not right? Tell us

Collaborative Fundlisted by Collaborative FundNew York · $500K – $1M

How we know: collabfund.com · Not right? Tell us

Pioneerlisted by PioneerToronto, Ontario

How we know: Y Combinator's founder network · pioneerfund.vc · open dataset · 5k.vc investor directory · Not right? Tell us

Ritual Capitallisted by Ritual CapitalMenlo Park · $100K – $500Kvia Chris Howard · inferred

How we know: Y Combinator's founder network · Not right? Tell us

Soma Capitallisted by Soma CapitalSacramento · $100K – $300K

How we know: Y Combinator's founder network · somacap.com · Not right? Tell us

Wayfinder Ventureslisted by Wayfinder VenturesSan Francisco · $300K – $1M

How we know: Wayfinder Ventures's portfolio page · Y Combinator's founder network · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us

Capitalize VCreportedChicago · $100K – $200K

How we know: Y Combinator's founder network · Not right? Tell us

Liquid VenturesreportedSan Francisco · $250K – $5M

How we know: Y Combinator's founder network · Not right? Tell us

Metsu Capitalreported

How we know: Y Combinator's founder network · Not right? Tell us

ReGen VenturesreportedByron Bay, New South Wales · $250K – $2.5M

How we know: Y Combinator's founder network · Not right? Tell us

Todd and Rahul’s Angel FundreportedSan Francisco · $300K – $500K

How we know: a partner's Signal profile · Y Combinator's founder network · Not right? Tell us

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 8

NephrogenNephrogen develops AI-powered AAV delivery vehicles for genetic medicines targeting kidney and pancreatic diseases. The company uses high-throughput in vivo screening to design tissue-specific viral vectors that are significantly more efficient and less immunogenic than existing alternatives.
AdaptyvAdaptyv Bio develops technologies for protein engineering that enable the design and testing of new proteins for applications in medicine, industrial enzymes, and functional materials. The company serves protein engineers and researchers developing therapeutic and industrial biological products.
AldevronAldevron provides products and services for biotechnology research and life sciences discovery, operating as a subsidiary of Danaher to enable breakthrough scientific advances.
LyonLyon trains a foundation model from scratch on a company's own customer event data, producing per-customer embeddings that power downstream predictions such as churn, credit risk, fraud, collections, income, and cross-sell. The model runs inside the customer's own cloud (AWS, GCP, or Azure) with the customer owning the weights and keeping data isolated.
GeronGeron is a biopharmaceutical company focused on developing therapies for blood cancer. The company has over 30 years of experience in research and clinical development.
Numerion LabsNumerion combines drug discovery expertise with machine learning and computational chemistry. The company applies AI to drug development.
Ligo BiosciencesLigo develops computational tools for enzyme design by combining large language models with specialized neural networks to enable scientists and AI agents to discover new enzymes and biological functions.
RasynRasyn.ai offers Marigold, an AI research assistant that lets scientists ask research questions, run tools, or delegate entire tasks, returning results such as structures, charts, code, and papers in panels. It provides 54 runnable tools, 40 executing on connected hardware and 14 on hosted endpoints.

Companies working in the same space as Anthrogen.

Legal entities · 1

corporate structure
Arctic Capture, Inc.

In the news

Anthrogen Funding | Complete Analysis | Extruct AIextruct.ai · Nov 2024Anthrogen 11/12/2024 Capital Raise - Gaebler.com Venture Capital Databasegaebler.com

Frequently asked questions

What does Anthrogen do?
Anthrogen develops Odyssey, a family of protein language models with 102 billion parameters designed for multi-objective protein design. The models provide an API for researchers and organizations in biotechnology and drug discovery.
Who founded Anthrogen?
Anthrogen was founded by Ankit Singhal, Connor Lee, Vignesh Karthik in 2024.
Who are Anthrogen's investors?
Anthrogen's investors include BoxGroup, Collaborative Fund, Pioneer, Ritual Capital, Soma Capital, Wayfinder Ventures, Y Combinator, Capitalize VC and 4 more.
Where is Anthrogen headquartered?
Anthrogen is headquartered in San Francisco, US.